Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Scandinavian Biopharma Holding AB

Closing information (x1000 EUR)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 14,012 Less Arrow 13,913 Less Arrow 10,944
Financial expenses 3 Less Arrow 1 More Arrow 46
Earnings before taxes 84 Less Arrow 62 Less Arrow 20
EBITDA 47 Less Arrow -32 More Arrow 116
Total assets 10,012 More Arrow 11,218 Less Arrow 10,812
Current assets 9,711 More Arrow 10,940 Less Arrow 10,635
Current liabilities 8,844 More Arrow 10,148 Less Arrow 9,455
Equity capital 1,168 Less Arrow 1,070 More Arrow 1,357
- share capital 22 More Arrow 23 Equal arrow 23
Employees (average) 35 Less Arrow 30 Less Arrow 27

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 11.7% Less Arrow 9.5% More Arrow 12.6%
Turnover per employee 400 More Arrow 464 Less Arrow 405
Profit as a percentage of turnover 0.6% Less Arrow 0.4% Less Arrow 0.2%
Return on assets (ROA) 0.9% Less Arrow 0.6% Equal arrow 0.6%
Current ratio 109.8% Less Arrow 107.8% More Arrow 112.5%
Return on equity (ROE) 7.2% Less Arrow 5.8% Less Arrow 1.5%
Change turnover 572 More Arrow 2,937 Less Arrow 2,515
Change turnover % 4% More Arrow 27% More Arrow 30%
Chg. No. of employees 5 Less Arrow 3 Less Arrow 2
Chg. No. of employees % 17% Less Arrow 11% Less Arrow 8%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.